Document is current
Any future updates will be listed below
-
Authors
Grit, Jamie L. http://orcid.org/0000-0002-5002-2940
McGee, Lauren E.
Tovar, Elizabeth A.
Essenburg, Curt J.
Wolfrum, Emily http://orcid.org/0000-0002-3018-0212
Beddows, Ian http://orcid.org/0000-0001-7403-0016
Williams, Kaitlin
Sheridan, Rachael T. C.
Schipper, Joshua L.
Adams, Marie http://orcid.org/0000-0001-7909-2339
Arumugam, Menusha
Vander Woude, Thomas
Gurunathan, Sharavana
Field, Jeffrey M. http://orcid.org/0000-0001-7161-7284
Wulfkuhle, Julia
Petricoin, Emanuel F. III
Graveel, Carrie R. http://orcid.org/0000-0001-7251-5642
Steensma, Matthew R. http://orcid.org/0000-0002-9003-6730
- License Information
-
More Information
Article History
Received: 6 June 2023
Revised: 16 February 2024
Accepted: 1 March 2024
First Online: 13 March 2024
Competing interests
: EFP is a paid consultant of and has stock equity in Theralink Technologies, Inc., Perthera Inc., and Ceres Nanosciences Inc. JW has stock ownership in Theralink Technologies LLC.
